The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIGT.L Regulatory News (SIGT)

  • There is currently no data for SIGT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Seneca Global Income & Growth Trust

21 Feb 2019 15:06

RNS Number : 7837Q
Seneca Global Income & Growth PLC
21 February 2019
 

 

London, UK, 21 February 2019

Edison issues review on Seneca Global Income & Growth Trust (SIGT)

Seneca Global Income & Growth Trust (SIGT) is a multi-asset, value investor, aiming to generate an average total return of at least CPI +6% pa (with low volatility) over the course of a typical investment cycle, while growing its dividend in real terms. In anticipation of a global recession in 2021, preceded in 2020 by pronounced stock market weakness, SIGT's managers are continuing to reduce the trust's equity exposure. Two new investments have recently been in specialist assets, a heterogeneous asset class, which diversifies the trust's revenue stream and offers the potential for enhanced total returns and lower portfolio volatility. SIGT has a progressive dividend policy; its annual distribution has compounded by c 4% pa over the last five years, and the trust currently offers a prospective dividend yield of 3.9%.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Gavin Wood, +44 (0)20 3681 2503

Investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRATBMATMBMTBJL
Date   Source Headline
1st Apr 20215:13 pmRNSTransaction in Own Shares
1st Apr 20212:31 pmRNSChange of Name
1st Apr 20211:41 pmRNSNet Asset Value(s)
1st Apr 20219:32 amRNSTotal Voting Rights
31st Mar 20211:09 pmRNSNet Asset Value(s)
30th Mar 202112:27 pmRNSNet Asset Value(s)
29th Mar 20215:22 pmRNSTransaction in Own Shares
29th Mar 202112:57 pmRNSNet Asset Value(s)
26th Mar 202110:28 amRNSNet Asset Value(s)
25th Mar 202112:52 pmRNSDirector/PDMR Shareholding
25th Mar 202110:25 amRNSNet Asset Value(s)
24th Mar 20215:19 pmRNSTransaction in Own Shares
24th Mar 202111:14 amRNSNet Asset Value(s)
23rd Mar 202111:46 amRNSNet Asset Value(s)
22nd Mar 202110:58 amRNSNet Asset Value(s)
19th Mar 202111:42 amRNSHolding(s) in Company
19th Mar 202111:38 amRNSNet Asset Value(s)
18th Mar 202111:28 amRNSNet Asset Value(s)
17th Mar 202111:58 amRNSNet Asset Value(s)
16th Mar 202111:26 amRNSNet Asset Value(s)
15th Mar 20214:46 pmRNSTransaction in Own Shares
15th Mar 202110:00 amRNSNet Asset Value(s)
12th Mar 202110:57 amRNSNet Asset Value(s)
11th Mar 202110:34 amRNSNet Asset Value(s)
10th Mar 202110:51 amRNSNet Asset Value(s)
9th Mar 20215:06 pmRNSTransaction in Own Shares
9th Mar 202111:33 amRNSNet Asset Value(s)
8th Mar 202111:38 amRNSNet Asset Value(s)
5th Mar 20214:38 pmRNSTransaction in Own Shares
5th Mar 202110:39 amRNSNet Asset Value(s)
4th Mar 202112:18 pmRNSNet Asset Value(s)
3rd Mar 20214:58 pmRNSTransaction in Own Shares
3rd Mar 202111:17 amRNSNet Asset Value(s)
2nd Mar 20212:40 pmRNSTransaction in Own Shares
2nd Mar 202110:39 amRNSNet Asset Value(s)
1st Mar 20214:37 pmRNSTransaction in Own Shares
1st Mar 202111:43 amRNSNet Asset Value(s)
1st Mar 202110:14 amRNSTotal Voting Rights
26th Feb 20214:54 pmRNSTransaction in Own Shares
26th Feb 202112:00 pmRNSNet Asset Value(s)
25th Feb 202111:29 amRNSNet Asset Value(s)
24th Feb 20214:44 pmRNSTransaction in Own Shares
24th Feb 202110:14 amRNSNet Asset Value(s)
23rd Feb 202112:09 pmRNSNet Asset Value(s)
22nd Feb 202111:23 amRNSNet Asset Value(s)
19th Feb 20215:05 pmRNSTransaction in Own Shares
19th Feb 20211:07 pmRNSNet Asset Value(s)
18th Feb 20214:54 pmRNSTransaction in Own Shares
18th Feb 202110:00 amRNSNet Asset Value(s)
17th Feb 202110:48 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.